BIOJECT ENTERS INTO A DISTRIBUTION AGREEMENT WITH BIOMEDICS SA FOR ITS
FULL LINE OF NEEDLE FREE INJECTION TECHNOLOGY IN MEXICO
Agreement increases the availability of Bioject products in a key market in the America’s and is another step in the Company’s global marketing strategy.
Tigard, OR –March 3, 2015 – Bioject Medical Technologies Inc. (OTC Pink: BJCT), a leading developer and manufacturer of needle-free injection technology, today announced that it has entered into a
distribution agreement with Biomedics , a leading medical supplies company based in Mexico City. Under the terms of this agreement, Biomedics will be the exclusive distributor of Bioject’s commercial needle-free injection products in Mexico and will now service Bioject’s current customers in Mexico. Product registration is already underway for those devices not yet approved for sale.
Stated Tony Chow, Bioject’s President and CEO, “Abraham Renner and his team are a great addition to our efforts to provide access to our technology around the world. They are a successful, established
medical products company with strong networks to Physicians, Healthcare Providers, and the Government. We are very much looking forward to a rewarding collaboration with Biomedics.”
Abraham Renner, President and CEO of Biomedics commented, “We are very excited with this new venture, being at the frontline of medical technology requires constant innovation and creativity.
BIOJECT represents for us this trend and are confident that these devices will revolutionize the way we see medicine today. Mexico, with over 100 million people will soon benefit of this new technology and
position itself as a vanguard in health treatments.” |
